Skip to content

Medical-device intelligence

PQP: Next Generation Sequencing Oncology Panel, Somatic Or Germline Variant Detection System

FDA product code PQP: Next Generation Sequencing Oncology Panel, Somatic Or Germline Variant Detection System. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
PQP
FDA device name
Next Generation Sequencing Oncology Panel, Somatic Or Germline Variant Detection System
Device class
3
Regulation number
Not provided
Medical specialty
Unknown
Review panel
PA

FDA definition

A next generation sequencing (NGS) oncology panel is a device used for the qualitative detection of germline or somatic variants in one or more cancer-related genes. The device is intended to be used on DNA or RNA isolated from human clinical specimens.
Explore unknown records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

0 clearance records and 18 recall records in the covered releases, across 4 source company names and 1 product codes. Dated history runs from Dec 4, 2017 to Jun 10, 2026.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202602
April 202600
May 202600
June 202601
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

18 matching records
Device / recordCompany in FDA recordSourceSource date
Hamilton Microlab STAR Liquid Handler; Protocol Configuration Tool (PCT) v2.0.0. Used to conduct F1CDx and F1LCDx.Z-2951-2026 · PQPFoundation Medicine, Inc.RecallAug 14, 2026FDA classification date
Protocol Configuration Tool (PCT) software v1.3.0 for Hamilton AutoLys STAR used within FoundationOneCDx (F1CDx) installed on Research Triangle P…Z-1937-2026 · PQPFoundation Medicine, Inc.RecallApr 23, 2026FDA classification date
Sequencing Agent SEQ0067, component of FoundationOne CDx (F1CDx)Z-1927-2026 · PQPFoundation Medicine, Inc.RecallApr 22, 2026FDA classification date
FoundationOne CDx (F1CDx), RAL-0003 version 31.0Z-0577-2026 · PQPFoundation Medicine, Inc.RecallNov 21, 2025FDA classification date
FoundationOne Liquid CDx (F1LCDx), TECH-0009 version 6.0Z-0578-2026 · PQPFoundation Medicine, Inc.RecallNov 21, 2025FDA classification date
MI Cancer Seek REF MSC000 UDI Code: (01)00860008613325(21)H5HJHDSXF MI Cancer Seek is a single-site assay intended to provide tumor mutational p…Z-2521-2025 · PQPCARIS LIFE SCIENCESRecallSep 4, 2025FDA classification date
FoundationOne Companion Diagnostic (F1CDx)Z-1890-2025 · PQPFoundation Medicine, Inc.RecallMay 30, 2025FDA classification date
FoundationOne Companion Diagnostic (F1CDx)Z-1891-2025 · PQPFoundation Medicine, Inc.RecallMay 30, 2025FDA classification date
FoundationOne Companion Diagnostic (F1CDx)Z-1747-2025 · PQPFoundation Medicine, Inc.RecallMay 12, 2025FDA classification date
Agilent Resolution ctDx FIRST Sample Collection Kit, 500032Z-1358-2023 · PQPAGILENT TECHNOLOGIES INC./USRecallApr 11, 2023FDA classification date
Oncomine Dx Target Test DNA Control-IVD for detection of DNA and RNA isolated from non-small cell lung cancer (NSCLC) tumor specimens, Catalog Nu…Z-1704-2020 · PQPLife Technologies CorporationRecallApr 14, 2020FDA record creation date
Oncomine Dx Target Test RNA Control- IVD for detection of DNA and RNA isolated from non-small cell lung cancer (NSCLC) tumor specimens, Catalog N…Z-1705-2020 · PQPLife Technologies CorporationRecallApr 14, 2020FDA record creation date
Oncomine Dx Target Test RNA/DNA Panel- IVD for detection of DNA and RNA isolated from non-small cell lung cancer (NSCLC) tumor specimens, Catalog…Z-1706-2020 · PQPLife Technologies CorporationRecallApr 14, 2020FDA record creation date
Ion Torrent Dx No Template Control Kit- IVD for detection of DNA and RNA isolated from non-small cell lung cancer (NSCLC) tumor specimens Catal…Z-1707-2020 · PQPLife Technologies CorporationRecallApr 14, 2020FDA record creation date
FoundationOne CDx test reportZ-0535-2020 · PQPFoundation Medicine, Inc.RecallNov 22, 2019FDA record creation date
FoundationOne CDx Test ResultsZ-0649-2019 · PQPFoundation Medicine, Inc.RecallDec 20, 2018FDA classification date
Oncomine Dx Target Test, (Model No. A32451), Oncomine Dx Target RNA/DNA Panel (Model No. A32441). A qualitative In Vitro Diagnostic test.Z-1480-2018 · PQPLife Technologies CorporationRecallApr 20, 2018FDA record creation date
Oncomine Dx Target Test User Guides and Assay Definition File, Model: A32461; UDI: (01)10190302006071(11)170911(10)1.8(240)A32461 The Oncomine …Z-1279-2018 · PQPLife Technologies CorporationRecallMar 30, 2018FDA record creation date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗